Page 206 - Read Online

Page 10 of 10 Berezin. Vessel Plus 2018;2:22 I http://dx.doi.org/10.20517/2574-1209.2018.23

outgrowth pro-angiogenic cell number and function do not correlate with left ventricular structure and function in conventional
hemodialysis patients: a cross-sectional study. Can J Kidney Health Dis 2015;2:25.
83. Heimrath J, Paprocka M, Czekanski A, Ledwozyw A, Kantor A, Dus D. Pregnancy-induced hypertension is accompanied by decreased
number of circulating endothelial cells and circulating endothelial progenitor cells. Arch Immunol Ther Exp (Warsz) 2014;62:353-6.
84. Grundmann M, Woywodt A, Kirsch T, Hollwitz B, Oehler K, Erdbruegger U, Haller H, Haubitz M.. Circulating endothelial cells: a
marker of vascular damage in patients with preeclampsia. Am J Obstet Gynecol 2008;198:e1-5.
85. Hunting CB, Noort WA, Zwaginga JJ. Circulating endothelial progenitor cells reflect the state of endothelium: vascular injury, repair
and neovasculatization. Vox Sang 2005;88:1-9.
86. Eirin A, Zhu XY, Ebrahimi B, Krier JD, Riester SM, van Wijnen AJ, Lerman A, Lerman LO. Intrarenal delivery of mesenchymal
stem cells and endothelial progenitor cells attenuates hypertensive cardiomyopathy in experimental renovascular hypertension. Cell
Transplant 2015;24:2041-53.
87. Marketou ME, Kalyva A, Parthenakis FI, Pontikoglou C, Maragkoudakis S, Kontaraki JE, Chlouverakis G, Zacharis EA, Patrianakos
A, Papadaki HA, Vardas PE. Circulating endothelial progenitor cells in hypertensive patients with increased arterial stiffness. J Clin
Hypertens (Greenwich) 2014;16:295-300.
88. Skrzypkowska MW, Ryba-Stanisławowska ME, Słomiński B, Gutknecht PG, Siebert J, Myśliwska JM. Association of circulating
progenitor cells with angiotensin II in newly diagnosed hypertensive patients. J Hum Hypertens 2017;32:46-53.
89. Skrzypkowska M, Słomiński B, Ryba-Stanisławowska M, Gutknecht P, Siebert J. Circulating CD34+ and CD34+VEGFR2+ progenitor
cells are associated with KLOTHO KL-VS polymorphism. Microvasc Res 2018; doi: 10.1016/j.mvr.2018.03.014.
90. King TF, McDermott JH. Endothelial progenitor cells and cardiovascular disease. J Stem Cells 2014;9:93-106.
91. Berezin AE, Kremzer AA, Martovitskaya YV, Samura TA, Berezina TA, Zulli A, Klimas J, Kruzliak P. The utility of biomarker risk
prediction score in patients with chronic heart failure. Int J Clin Exp Med 2015;8:18255-64.
92. Berezin AE, Kremzer AA. Analysis of various subsets of circulating mononuclear cells in asymptomatic coronary artery disease. J Clin
Med 2013;2:32-44.
93. Giles TD, Sander GE. Endothelial progenitor cells as a biomarker for transitional phenotypes in hypertension. J Clin Hypertens
(Greenwich) 2015;17:580-1.